Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byEli Lilly
Date7/2010

General Information

Offices

Headquarters
840 Memorial Drive
Cambridge, MA, 02139
USA

People

Director of Finance

Funding

TOTAL $55M
FUNDING TOTAL $55M
Series A, 10/2008
Bessemer Venture Partners
Third Rock Ventures
Frazier Healthcare Ventures
$20M
Series B, 1/2010
MPM Capital
$35M

Tags

Alnara Pharmaceuticals

Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company’s innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.

Recent Milestones

Videos

Screenshots

Alnara Pharmaceuticals screenshot
Above: Alnara Pharmaceuticals Screenshot -- #1
Uploaded: 6/25/09

Sources

  1. Lilly buys Alnara for undisclosed sum (fiercebiotech.com) [edit]
  2. Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round (xconomy.com) [edit]
  3. http://www.fiercebiotech.com/story/alnara-grabs-35m-vc-cash-it-aims-nda/2010-01-28?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0 (fiercebiotech.com) [edit]
Edit This Page
Last Edited 12/21/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy